Reply to the Editor  by Gunn, Tyler M. et al.
Letters to the Editoravoid this undesirable outcome after
sympathectomy.
We are indeed concerned with
a strong recommendation of a
‘‘complete and adequate resection
for relief of symptoms,’’ and we
believe that attention must be brought
to this subject.
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regarding the extent of sympathetic
chain removal and resulting com-
pensatory hyperhidrosis (CH) after
endoscopic thoracic sympathectomy
(ETS).1 There is little disagreement
that adequately powered randomized
prospective trials are superior to
nonrandomized prospective studies2444 The Journal of Thoracic andor retrospective reviews. Despite a
large body of literature on the topic,
however, few investigations have
performed randomized, clinical trials.
Significant controversy remains
regarding the optimal level and
extent of sympathetic chain removal
in the treatment of primary hyper-
hidrosis of the hands, axillae, feet,
and face.
The Society of Thoracic Surgeons
assembled an expert task force
to comprehensively review 102
studies, including 12 randomized
clinical trials, which determined that
the number of sympathetic levels
interrupted has been inconclusive as
a risk factor for moderate to severe
CH.2 These findings were consistent
with those previously published by
Kopelman and Hashmonai.3 In their
review of 87 studies, they statistically
determined that the literature did not
support claims that restricting the
extent of sympathetic ablation
resulted in a statistically significant
reduction in the frequency of CH.2
Even though we perform more
extensive resections (T2-T5 and
T2-T6) than commonly described in
the literature, our results are similar
or better than those in other studies.1
A recently published randomized
prospective trial by Cai and
colleagues4 containing 116 patients
with primary palmar hyperhidrosis
found that there were no significant
differences with respect to the
frequency of minor or severe CH in
patients who received either T2 to
T3 or more extensive T2 to T4 resec-
tions.4 A study by Leseche and col-
leagues,5 which compared T2 to T4
and T2 to T5 resections with more
limited ETS, also found that incidence
and severity of CH was not associated
with the extent of resection.
The physiologic basis of CH is still
not well understood, and the extent of
resection is only one of many factors
that likely influence the development
of severe CH. These include sex,
preoperative hyperhidrosis location
and degree,6 and possibly body massCardiovascular Surgery c November 20index, age, ethnicity, lifestyle, and
climate. Some consensus has been
reached regarding the recommended
location of interruption according to
the distribution of sweating, with T3
to T4 recommended for palmar sweat-
ing and T4 to T5 recommended for
both palmar, plantar and axillary
hyperhidrosis.2 Because many of our
patients had widespread symptoms,
including palmar, plantar, and axillary
sweating,we decided to tailor the oper-
ation on the basis their symptoms and
performed adequately extensive resec-
tions to improve patient satisfaction.1
Surgeons must balance the possibility
of persistent hyperhidrosis after inade-
quate resection against the risks of un-
necessarily excessive interruption that
could possibly lead to bradycardia,
Horner syndrome, or CH. At our insti-
tution, primarily extensive ETS was
performed between T2 to T5 and T2
to T6with positive patient satisfaction,
as well as some of the lowest rates of
CH reported in the literature.1 In light
of our experience and our review of
the literature, we therefore do not
recommend limiting the extent of
resection in an attempt to reduce the
incidence or severity of CH. Further
investigation is required, however, for
a better understanding of patient risk
factors for development of CH in addi-
tion to surgical technique and extent of
ETS.
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